Literature DB >> 31692368

Associations Between microRNA Polymorphisms and Development of Coronary Artery Disease: A Case-Control Study.

Hao Qiu1, Zheng Chen2, Lu Lv3, Weifeng Tang3, Rong Hu4.   

Abstract

Coronary artery disease (CAD), a common cardiovascular disease, has become a vital cause of mortality worldwide. Genetic microRNA (miR) polymorphisms might contribute to CAD susceptibility. In this study, we selected miR-146a, miR-196a2, and miR-499 single nucleotide polymorphisms and conducted a case-control study. In total, 505 CAD cases and 1109 controls were recruited. We used SNPscan™ genotyping assay to obtain genotyping of miR rs2910164, rs11614913, and rs3746444 variants. We found that miR-196a2 rs11614913 T > C decreased the susceptibility of myocardial infarction (MI) (TC vs. TT: adjusted p = 0.007 and CC/TC vs. TT: adjusted p = 0.012). In female subgroup, our results indicated that miR-196a2 rs11614913 T > C variants might also decrease the susceptibility of CAD (TC vs. TT: adjusted p = 0.017 and TC/CC vs. TT: adjusted p = 0.015). In summary, these results suggest that miR-196a2 rs11614913 T > C locus decreases the susceptibility of CAD in female and MI subgroups. However, further studies are needed to validate the potential associations of miR-196a2 rs11614913 locus with CAD.

Entities:  

Keywords:  coronary artery disease; microRNA; polymorphism; risk

Mesh:

Substances:

Year:  2019        PMID: 31692368     DOI: 10.1089/dna.2019.4963

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  8 in total

Review 1.  Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review.

Authors:  Yang Yang; Xiajun Shi; Zhengxun Du; Gendong Zhou; Xiaohong Zhang
Journal:  Herz       Date:  2021-12-08       Impact factor: 1.443

2.  MicroRNA Variants miR-27a rs895819 and miR-423 rs6505162, but not miR-124-1 rs531564, are Linked to Endometriosis and its Severity.

Authors:  S O Jaafar; J O Jaffar; S A Ibrahim; K K Jarjees
Journal:  Br J Biomed Sci       Date:  2022-01-07       Impact factor: 2.432

3.  The Association between Single Nucleotide Polymorphisms, including miR-499a Genetic Variants, and Dyslipidemia in Subjects Treated with Pharmacological or Phytochemical Lipid-Lowering Agents.

Authors:  Angelica Giuliani; Alberto Montesanto; Giulia Matacchione; Laura Graciotti; Deborah Ramini; Olga Protic; Roberta Galeazzi; Roberto Antonicelli; Elena Tortato; Anna Rita Bonfigli; Jacopo Sabbatinelli; Fabiola Olivieri
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

4.  Association study of miR-149, miR-196a2, and miR-499a polymorphisms with coronary artery aneurysm of Kawasaki disease in southern Chinese population.

Authors:  Lanyan Fu; Yufen Xu; Hongyan Yu; Lei Pi; Jinqing Li; Huazhong Zhou; Li Zhang; Tingfang Zhang; Di Che; Xiaoqiong Gu
Journal:  J Gene Med       Date:  2022-01-30       Impact factor: 4.152

5.  Association between microRNA-146a, -499a and -196a-2 SNPs and non-small cell lung cancer: a case-control study involving 2249 subjects.

Authors:  Hao Qiu; Zhiqiang Xie; Weifeng Tang; Chao Liu; Yafeng Wang; Haiyong Gu; Qingfeng Zheng
Journal:  Biosci Rep       Date:  2021-02-26       Impact factor: 3.840

Review 6.  Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Cardiovasc Med       Date:  2021-04-12

Review 7.  Implication of non-coding RNA-mediated ROCK1 regulation in various diseases.

Authors:  Soudeh Ghafouri-Fard; Yadollah Poornajaf; Bashdar Mahmud Hussen; Atefe Abak; Hamed Shoorei; Mohammad Taheri; Guive Sharifi
Journal:  Front Mol Biosci       Date:  2022-09-13

8.  Screening of Biological Target Molecules Related to Glucocorticoid-Induced Cataract (GIC) on the Basis of Constructing ceRNA Network.

Authors:  Zhan Shi; Xiumei Zhao; Ying Su; Chao Wang; Ping Liu; Hongyan Ge
Journal:  Biochem Genet       Date:  2021-06-02       Impact factor: 1.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.